This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zika mRNA Vaccine (Moderna)
Moderna Therapeutics, Inc.
Drug Names(s): Zika vaccine
Description: Moderna is developing a Zika messenger RNA (mRNA) vaccine utilizing its mRNA Therapeutics platform technology. The modified mRNA is designed to be taken up by the cells in specific tissues and organs. These modifications also enable the mRNA to elude the body’s innate immune response. Once delivered, like native mRNA, the modified mRNA is translated by the ribosome to express protein within targeted tissues.
Zika mRNA Vaccine (Moderna) News
Pink Sheet Zika Vaccines Might Be Approved By 2020
Additional information available to subscribers only: